{"id":5575,"date":"2025-03-19T16:15:30","date_gmt":"2025-03-19T13:15:30","guid":{"rendered":"https:\/\/mehmettetikoglu.com\/?p=5575"},"modified":"2026-04-16T16:42:25","modified_gmt":"2026-04-16T13:42:25","slug":"goz-ici-iltihabi","status":"publish","type":"post","link":"https:\/\/mehmettetikoglu.com\/ar\/goz-ici-iltihabi\/","title":{"rendered":"G\u00f6z \u0130\u00e7i \u0130ltihab\u0131"},"content":{"rendered":"<p>G\u00f6z\u00fcn i\u00e7 tabakalar\u0131nda meydana gelen iltihabi durumlar vard\u0131r. Bu durumlar\u0131 tan\u0131mlamak i\u00e7in kullan\u0131lan genel ifade <strong>g\u00f6z i\u00e7i iltihab\u0131<\/strong>d\u0131r. En s\u0131k tutulan yap\u0131, g\u00f6z\u00fcn orta tabakas\u0131 olan uvead\u0131r. Bu nedenle t\u0131bbi olarak \u00e7o\u011fu zaman \u00fcveit ad\u0131yla an\u0131l\u0131r. Tek g\u00f6zde ya da her iki g\u00f6zde birden g\u00f6r\u00fclebilir ve tedavi edilmedi\u011finde ciddi g\u00f6rme kay\u0131plar\u0131na yol a\u00e7abilir.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_76 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">\u0130\u00e7indekiler<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"\u062a\u0628\u062f\u064a\u0644 \u062c\u062f\u0648\u0644 \u0627\u0644\u0645\u062d\u062a\u0648\u0649\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">\u062a\u0628\u062f\u064a\u0644<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #212d3d;color:#212d3d\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #212d3d;color:#212d3d\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/mehmettetikoglu.com\/ar\/goz-ici-iltihabi\/#Goz_Ici_Iltihabi_Belirtileri_Ve_Nedenleri\" >G\u00f6z \u0130\u00e7i \u0130ltihab\u0131 Belirtileri Ve Nedenleri<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/mehmettetikoglu.com\/ar\/goz-ici-iltihabi\/#Goz_Ici_Iltihabi_Kimlerde_Gorulur\" >G\u00f6z \u0130\u00e7i \u0130ltihab\u0131 Kimlerde G\u00f6r\u00fcl\u00fcr?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/mehmettetikoglu.com\/ar\/goz-ici-iltihabi\/#Goz_Ici_Iltihabi_Tedavi_Yontemleri_Nelerdir\" >G\u00f6z \u0130\u00e7i \u0130ltihab\u0131 Tedavi Y\u00f6ntemleri Nelerdir?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/mehmettetikoglu.com\/ar\/goz-ici-iltihabi\/#Goz_Ici_Iltihabi_Tedavi_Sonrasi_Surec_Nasildir\" >G\u00f6z \u0130\u00e7i \u0130ltihab\u0131 Tedavi Sonras\u0131 S\u00fcre\u00e7 Nas\u0131ld\u0131r?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Goz_Ici_Iltihabi_Belirtileri_Ve_Nedenleri\"><\/span>G\u00f6z \u0130\u00e7i \u0130ltihab\u0131 Belirtileri Ve Nedenleri<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-6001 alignleft\" src=\"https:\/\/mehmettetikoglu.com\/wp-content\/uploads\/2025\/03\/goz-iltihabi-2.jpg\" alt=\"G\u00f6z \u0130\u00e7i \u0130ltihab\u0131\" width=\"380\" height=\"199\" srcset=\"https:\/\/mehmettetikoglu.com\/wp-content\/uploads\/2025\/03\/goz-iltihabi-2.jpg 1200w, https:\/\/mehmettetikoglu.com\/wp-content\/uploads\/2025\/03\/goz-iltihabi-2-18x9.jpg 18w\" sizes=\"(max-width: 380px) 100vw, 380px\" \/><\/p>\n<p>G\u00f6z sa\u011fl\u0131\u011f\u0131n\u0131 etkileyen iltihabi durumlar bazen sessiz ilerler. \u0130lk d\u00f6nemde \u015fik\u00e2yetler hafif olabilir. Zamanla g\u00fcnl\u00fck ya\u015fam\u0131 zorla\u015ft\u0131ran belirtiler ortaya \u00e7\u0131kar. G\u00f6rme kalitesi d\u00fc\u015febilir. I\u015f\u0131\u011fa kar\u015f\u0131 hassasiyet geli\u015febilir. Bu de\u011fi\u015fimler \u00e7o\u011fu zaman yorgunlukla kar\u0131\u015ft\u0131r\u0131l\u0131r. Oysa erken fark edilen belirtiler, kal\u0131c\u0131 hasar\u0131n \u00f6n\u00fcne ge\u00e7ebilir. Bu nedenle g\u00f6zde hissedilen her farkl\u0131l\u0131k dikkatle izlenmelidir.<\/p>\n<p>En s\u0131k g\u00f6r\u00fclen belirtiler aras\u0131nda g\u00f6zde k\u0131zar\u0131kl\u0131k ve a\u011fr\u0131 yer al\u0131r. <strong>G\u00f6z i\u00e7i iltihab\u0131<\/strong> olan ki\u015filer \u0131\u015f\u0131\u011fa bakmakta zorlanabilir. G\u00f6rme bulan\u0131kl\u0131\u011f\u0131 s\u0131k tarif edilir. G\u00f6z \u00f6n\u00fcnde u\u00e7u\u015fan cisimler hissedilebilir. Baz\u0131 hastalarda ba\u015f a\u011fr\u0131s\u0131 ve g\u00f6z \u00e7evresinde dolgunluk hissi e\u015flik eder. Belirtiler tek g\u00f6zde ba\u015flayabilir. Zamanla her iki g\u00f6z\u00fc de etkileyebilir. \u015eik\u00e2yetlerin \u015fiddeti iltihab\u0131n yerine g\u00f6re de\u011fi\u015fir.<\/p>\n<p>Nedenler her zaman net de\u011fildir. Ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin kendi dokular\u0131na kar\u015f\u0131 tepki vermesi \u00f6nemli bir etkendir. Romatizmal hastal\u0131klar bu durumu tetikleyebilir. Baz\u0131 enfeksiyonlar g\u00f6z i\u00e7i dokular\u0131 etkileyebilir. Travmalar ve cerrahi giri\u015fimler de risk olu\u015fturur. Nadiren sistemik hastal\u0131klar\u0131n bir par\u00e7as\u0131 olarak ortaya \u00e7\u0131kabilir. Bu nedenle altta yatan nedenlerin ara\u015ft\u0131r\u0131lmas\u0131 \u00f6nemlidir.<\/p>\n<p>Baz\u0131 ki\u015filerde <strong>g\u00f6z i\u00e7i iltihab\u0131<\/strong> belirti vermeden rutin muayenede saptanabilir. Bu durum d\u00fczenli kontrollerin \u00f6nemini art\u0131r\u0131r. Tedavi gecikti\u011finde g\u00f6rme kayb\u0131 riski y\u00fckselir. Erken tan\u0131 ise s\u00fcreci kontrol alt\u0131na almay\u0131 kolayla\u015ft\u0131r\u0131r. \u015eik\u00e2yetler hafif olsa bile ihmal edilmemelidir. Zaman\u0131nda yap\u0131lan de\u011ferlendirme, hem g\u00f6rmenin korunmas\u0131n\u0131 hem de ya\u015fam kalitesinin s\u00fcrd\u00fcr\u00fclmesini sa\u011flar.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Goz_Ici_Iltihabi_Kimlerde_Gorulur\"><\/span>G\u00f6z \u0130\u00e7i \u0130ltihab\u0131 Kimlerde G\u00f6r\u00fcl\u00fcr?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>G\u00f6z sa\u011fl\u0131\u011f\u0131n\u0131 etkileyen iltihabi hastal\u0131klar her ya\u015fta ortaya \u00e7\u0131kabilir. Ancak baz\u0131 ki\u015filer di\u011ferlerine g\u00f6re daha y\u00fcksek risk ta\u015f\u0131r. Ba\u011f\u0131\u015f\u0131kl\u0131k sistemi, genetik yap\u0131 ve \u00e7evresel fakt\u00f6rler bu durumu etkiler. Bu nedenle risk gruplar\u0131n\u0131n bilinmesi erken tan\u0131 a\u00e7\u0131s\u0131ndan \u00f6nemlidir. D\u00fczenli g\u00f6z muayeneleri, sessiz ilerleyen hastal\u0131klar\u0131n fark edilmesini sa\u011flar.<\/p>\n<p>Gen\u00e7 ve orta ya\u015f grubundaki bireylerde daha s\u0131k g\u00f6r\u00fcl\u00fcr. \u00d6zellikle otoimm\u00fcn hastal\u0131\u011f\u0131 olan ki\u015filerde risk artar. Romatizmal hastal\u0131klar, ba\u011f\u0131rsak iltihaplar\u0131 ve baz\u0131 cilt hastal\u0131klar\u0131 bu grupta yer al\u0131r. Ayr\u0131ca ge\u00e7irilmi\u015f enfeksiyonlar sonras\u0131 ba\u011f\u0131\u015f\u0131kl\u0131k tepkisi tetiklenebilir. Bu bireylerde g\u00f6zle ilgili belirtiler daha yak\u0131ndan izlenmelidir.<\/p>\n<p>Ba\u011f\u0131\u015f\u0131kl\u0131k sistemiyle ili\u015fkili hastal\u0131\u011f\u0131 olan ki\u015filerde <strong>g\u00f6z i\u00e7i iltihab\u0131<\/strong> g\u00f6r\u00fclme olas\u0131l\u0131\u011f\u0131 daha y\u00fcksektir. Aile \u00f6yk\u00fcs\u00fcnde benzer sorunlar bulunan bireyler de risk alt\u0131ndad\u0131r. Uzun s\u00fcre ba\u011f\u0131\u015f\u0131kl\u0131k bask\u0131lay\u0131c\u0131 ila\u00e7 kullanan hastalarda da iltihabi s\u00fcre\u00e7ler geli\u015febilir. Travma veya g\u00f6z ameliyat\u0131 ge\u00e7iren ki\u015filerde de bu durum ortaya \u00e7\u0131kabilir. Bu gruplarda d\u00fczenli takip b\u00fcy\u00fck \u00f6nem ta\u015f\u0131r.<\/p>\n<p>\u00c7ocuklarda ve ileri ya\u015flarda da g\u00f6r\u00fclebilir. \u00c7ocukluk \u00e7a\u011f\u0131nda baz\u0131 do\u011fumsal ya da genetik hastal\u0131klarla ili\u015fkili olabilir. \u0130leri ya\u015flarda ise enfeksiyonlar ve genel sa\u011fl\u0131k durumundaki bozulmalar etkili olur. Ya\u015f fark etmeksizin g\u00f6zde a\u011fr\u0131, k\u0131zar\u0131kl\u0131k veya g\u00f6rme de\u011fi\u015fikli\u011fi ciddiye al\u0131nmal\u0131d\u0131r. Erken de\u011ferlendirme, g\u00f6rme kayb\u0131 riskini azalt\u0131r. Risk grubunda olan ki\u015filerin kontrollerini aksatmamas\u0131, g\u00f6z sa\u011fl\u0131\u011f\u0131n\u0131n korunmas\u0131nda temel rol oynar.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Goz_Ici_Iltihabi_Tedavi_Yontemleri_Nelerdir\"><\/span>G\u00f6z \u0130\u00e7i \u0130ltihab\u0131 Tedavi Y\u00f6ntemleri Nelerdir?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><img decoding=\"async\" class=\"wp-image-6003 alignright\" src=\"https:\/\/mehmettetikoglu.com\/wp-content\/uploads\/2025\/03\/goz-iltihabi-1.jpg\" alt=\"G\u00f6z \u0130\u00e7i \u0130ltihab\u0131\" width=\"380\" height=\"199\" srcset=\"https:\/\/mehmettetikoglu.com\/wp-content\/uploads\/2025\/03\/goz-iltihabi-1.jpg 1200w, https:\/\/mehmettetikoglu.com\/wp-content\/uploads\/2025\/03\/goz-iltihabi-1-18x9.jpg 18w\" sizes=\"(max-width: 380px) 100vw, 380px\" \/><\/p>\n<p>Tedavi s\u00fcreci, iltihab\u0131n yerine ve \u015fiddetine g\u00f6re planlan\u0131r. \u00d6ncelikle ayr\u0131nt\u0131l\u0131 bir g\u00f6z muayenesi yap\u0131l\u0131r. G\u00f6z i\u00e7i dokular dikkatle de\u011ferlendirilir. Ama\u00e7, iltihab\u0131 h\u0131zl\u0131 \u015fekilde kontrol alt\u0131na almakt\u0131r. Ayn\u0131 zamanda g\u00f6rme kayb\u0131n\u0131 \u00f6nlemek hedeflenir. Tedavi bireysel olarak belirlenir. Her hastada ayn\u0131 y\u00f6ntem uygulanmaz. Erken m\u00fcdahale, s\u00fcrecin ba\u015far\u0131s\u0131n\u0131 do\u011frudan etkiler.<\/p>\n<p>Tedavinin temelini <strong>g\u00f6z i\u00e7i iltihab\u0131<\/strong> i\u00e7in kullan\u0131lan ila\u00e7lar olu\u015fturur. En s\u0131k ba\u015fvurulan y\u00f6ntem kortizon i\u00e7eren g\u00f6z damlalar\u0131d\u0131r. Bu damlalar iltihab\u0131 bask\u0131lar. Gerekli durumlarda a\u011f\u0131zdan ila\u00e7 tedavisi planlanabilir. Baz\u0131 hastalarda enjeksiyon uygulamalar\u0131 tercih edilir. Enfeksiyon saptan\u0131rsa buna y\u00f6nelik \u00f6zel ila\u00e7lar kullan\u0131l\u0131r. Tedavi s\u00fcresi, iltihab\u0131n yan\u0131t\u0131na g\u00f6re ayarlan\u0131r. \u0130la\u00e7lar mutlaka doktor kontrol\u00fcnde kullan\u0131lmal\u0131d\u0131r.<\/p>\n<p>Altta yatan sistemik bir hastal\u0131k varsa, tedavi bu durumu da kapsar. Romatizmal veya otoimm\u00fcn hastal\u0131klarda ilgili bran\u015flarla birlikte hareket edilir. Ba\u011f\u0131\u015f\u0131kl\u0131k sistemini d\u00fczenleyen ila\u00e7lar bu a\u015famada g\u00fcndeme gelebilir. Ama\u00e7, iltihab\u0131n tekrar etmesini \u00f6nlemektir. D\u00fczenli takip bu nedenle b\u00fcy\u00fck \u00f6nem ta\u015f\u0131r. Tedavi yaln\u0131zca belirtilerin ge\u00e7mesiyle sonland\u0131r\u0131lmaz.<\/p>\n<p>Tedavi s\u00fcrecinde hasta e\u011fitimi \u00f6nemlidir. G\u00f6z\u00fcn korunmas\u0131 gerekir. I\u015f\u0131k hassasiyeti olan ki\u015filer g\u00fcne\u015f g\u00f6zl\u00fc\u011f\u00fc kullanmal\u0131d\u0131r. Kontrol muayeneleri aksat\u0131lmamal\u0131d\u0131r. Tedaviye uyum, g\u00f6rme sa\u011fl\u0131\u011f\u0131n\u0131n korunmas\u0131nda belirleyici rol oynar. Do\u011fru y\u00f6ntemlerle y\u00f6netildi\u011finde iltihap b\u00fcy\u00fck oranda kontrol alt\u0131na al\u0131nabilir. Erken tan\u0131 ve d\u00fczenli takip, kal\u0131c\u0131 hasar riskini \u00f6nemli \u00f6l\u00e7\u00fcde azalt\u0131r.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Goz_Ici_Iltihabi_Tedavi_Sonrasi_Surec_Nasildir\"><\/span>G\u00f6z \u0130\u00e7i \u0130ltihab\u0131 Tedavi Sonras\u0131 S\u00fcre\u00e7 Nas\u0131ld\u0131r?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Tedavi tamamland\u0131ktan sonra iyile\u015fme s\u00fcreci dikkatli bir izlem gerektirir. \u0130lk g\u00fcnlerde g\u00f6zde hassasiyet ve yorgunluk hissi olabilir. Bu durum \u00e7o\u011fu zaman ge\u00e7icidir. \u0130la\u00e7lar doktorun \u00f6nerdi\u011fi doz ve s\u00fcrede kullan\u0131lmal\u0131d\u0131r. Tedavinin erken b\u0131rak\u0131lmas\u0131, belirtilerin yeniden ortaya \u00e7\u0131kmas\u0131na neden olabilir. Bu nedenle hastan\u0131n s\u00fcrece sab\u0131rla uyum g\u00f6stermesi \u00f6nemlidir.<\/p>\n<p>Kontrol muayeneleri tedavi sonras\u0131 d\u00f6nemin temel par\u00e7as\u0131d\u0131r. Bu kontrollerde g\u00f6z i\u00e7i yap\u0131lar de\u011ferlendirilir. G\u00f6rme d\u00fczeyindeki de\u011fi\u015fiklikler yak\u0131ndan izlenir. Gerekli g\u00f6r\u00fcld\u00fc\u011f\u00fcnde ek tetkikler yap\u0131labilir. Bu takipler, iltihab\u0131n tamamen bask\u0131lan\u0131p bask\u0131lanmad\u0131\u011f\u0131n\u0131 g\u00f6sterir. Ayn\u0131 zamanda olas\u0131 yan etkilerin erken fark edilmesini sa\u011flar. D\u00fczenli kontroller, uzun vadeli g\u00f6rme sa\u011fl\u0131\u011f\u0131 i\u00e7in kritik rol oynar.<\/p>\n<p>G\u00fcnl\u00fck ya\u015fama d\u00f6n\u00fc\u015f a\u015famal\u0131 olmal\u0131d\u0131r. G\u00f6zleri zorlayan aktivitelerden bir s\u00fcre ka\u00e7\u0131n\u0131lmas\u0131 \u00f6nerilir. Uzun s\u00fcre ekrana bakmak ve yo\u011fun \u0131\u015f\u0131\u011fa maruz kalmak rahats\u0131zl\u0131k olu\u015fturabilir. G\u00fcne\u015f g\u00f6zl\u00fc\u011f\u00fc kullan\u0131m\u0131 bu d\u00f6nemde faydal\u0131d\u0131r. Yeterli uyku ve dengeli beslenme, v\u00fccudun toparlanmas\u0131n\u0131 destekler. Stresin azalt\u0131lmas\u0131 da iyile\u015fme s\u00fcrecine olumlu katk\u0131 sa\u011flar.<\/p>\n<p>\u0130yile\u015fme tamamland\u0131\u011f\u0131nda <strong>g\u00f6z i\u00e7i iltihab\u0131<\/strong> ge\u00e7iren bireylerin d\u00fczenli kontrolleri s\u00fcrd\u00fcrmesi \u00f6nemlidir. Bu yakla\u015f\u0131m, tekrar riskinin erken fark edilmesine yard\u0131mc\u0131 olur. K\u00fc\u00e7\u00fck belirtiler bile ciddiye al\u0131nmal\u0131d\u0131r. Tedavi sonras\u0131 s\u00fcrecin bilin\u00e7li y\u00f6netilmesi, g\u00f6rme kayb\u0131 riskini azalt\u0131r. Uygun takip ve sa\u011fl\u0131kl\u0131 ya\u015fam al\u0131\u015fkanl\u0131klar\u0131 ile g\u00f6z sa\u011fl\u0131\u011f\u0131 uzun vadede korunabilir.<\/p>","protected":false},"excerpt":{"rendered":"<p>G\u00f6z\u00fcn i\u00e7 tabakalar\u0131nda meydana gelen iltihabi durumlar vard\u0131r. Bu durumlar\u0131 tan\u0131mlamak i\u00e7in kullan\u0131lan genel ifade g\u00f6z i\u00e7i iltihab\u0131d\u0131r. En s\u0131k tutulan yap\u0131, g\u00f6z\u00fcn orta tabakas\u0131 olan uvead\u0131r. Bu nedenle t\u0131bbi olarak \u00e7o\u011fu zaman \u00fcveit ad\u0131yla an\u0131l\u0131r. Tek g\u00f6zde ya da her iki g\u00f6zde birden g\u00f6r\u00fclebilir ve tedavi edilmedi\u011finde ciddi g\u00f6rme kay\u0131plar\u0131na yol a\u00e7abilir. G\u00f6z \u0130\u00e7i [&hellip;]<\/p>","protected":false},"author":1,"featured_media":6002,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5575","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/mehmettetikoglu.com\/ar\/wp-json\/wp\/v2\/posts\/5575","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mehmettetikoglu.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mehmettetikoglu.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mehmettetikoglu.com\/ar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mehmettetikoglu.com\/ar\/wp-json\/wp\/v2\/comments?post=5575"}],"version-history":[{"count":4,"href":"https:\/\/mehmettetikoglu.com\/ar\/wp-json\/wp\/v2\/posts\/5575\/revisions"}],"predecessor-version":[{"id":6004,"href":"https:\/\/mehmettetikoglu.com\/ar\/wp-json\/wp\/v2\/posts\/5575\/revisions\/6004"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mehmettetikoglu.com\/ar\/wp-json\/wp\/v2\/media\/6002"}],"wp:attachment":[{"href":"https:\/\/mehmettetikoglu.com\/ar\/wp-json\/wp\/v2\/media?parent=5575"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mehmettetikoglu.com\/ar\/wp-json\/wp\/v2\/categories?post=5575"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mehmettetikoglu.com\/ar\/wp-json\/wp\/v2\/tags?post=5575"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}